Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells

Journal of Cellular Biochemistry

Volumn 101, Issue 2, 2007, Pages 442-450

  Ho, Feng M ^a,b   Liu, Shing H ^c   Lin, Wan W ^c   Liau, Chiau S ^d  

^a TAO YUAN GENERAL HOSPITAL   (Taiwan)

^b Department of Health ^*  (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Apoptosis; High glucose; Human endothelial cell; Matrix metalloproteinase

Indexed keywords

ASCORBIC ACID; GELATINASE A; GELATINASE B; GLUCOSE; ILOMASTAT; REACTIVE OXYGEN METABOLITE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; WESTERN BLOTTING;

CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 34247898922     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21192     Document Type: Article

References (35)

1. Borden P, Heller RA. 1997. Transcriptional control of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Crit Rev Eukaryot Gene Exp 7:159-178.
2. Carmichael DF, Sommer A, Thompson RC, Anderson DC, Smith CG, Welgus HG, Stricklin GP. 1986. Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA 83(8):2407-2411.
3. Chen ZL, Strickland S. 1997. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91(7):917-925.
4. Creemers EE, Cleutjens JP, Smits JF, Daemen MJAP. 2001. Matrix metalloproteinase inhibition after myocardial infarction: A new approach to prevent heart failure? Circ Res 89:201-210.
5. Death AK, Fisher EJ, McGrath KCY, Yue DK. 2003. High glucose alters matrix metalloproteinase expression in two key vascular cells: Potential impact on atherosclerosis in diabetes. Atherosclerosis 168:263-269.
6. Fisher E, McLennan SV, Tada H, Heffernan S, Yue DK, Turtle JR. 1991. Interaction of ascorbic acid and glucose on the production of collagen and proteoglycan by fibroblasts. Diabetes 40:371-376.
7. Galis ZS, Sukhova GK, Lark MW, Libby P. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503.
8. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P. 1995. Enhanced expression Of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann New York Acad Sci 748:501-507.
9. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He CS. 1989. Human 72 kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA 86:8207-8211.
10. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. 1997. Tissue inhibitors of metalloprteinases: Structure, regulation and biological function. Eur J Cell Biol 74:111-122.
11. Ho FM, Liu SH, Liau CS, Huang PJ, Shiah SG, Lin-Shiau SY. 1999. Nitric oxide prevents apoptosis of human endothelial cells from high glucose exposure during early stage. J Cell Biochem 75:258-263.
12. 2-terminal kinase and caspase-3. Circulation 101:2618-2624.
13. Ho FM, Lin WW, Chen BC, Chao CM, Yang CR, Lin LY, Lai CC, Liu SH, Liau CS. 2006. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-κB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cell Signal 18:391-399.
14. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, Ueno T, Sugi K, Imaizumi T. 1998. Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32:368-372.
15. Kannel WB, Mcgee DL. 1979. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study. Diabetes Care 2:120-126.
16. Kim D, Kim S, Koh H, Yoon SO, Chung AS, Cho KS, Chung J. 2001. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 15:1953-1962.
17. Komorowski J, Pasicka Z, Jankiewicz-Wika J, Stepien H. 2002. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer. Thyroid 12:655-662.
18. Lafleur MA, Hollenberg MD, Atkinson SJ, Knauper V, Murphy G, Edwards DR. 2001. Activation of pro-matrix metalloproteinase-2 (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein cells and generates a distinct 63 kDa active species. Biochem J 357(Pt 1):107-115.
19. Liotta LA, Stetler-Stevenson WG. 1990. Metalloproteinases and cancer invasion. Semin Cancer Biol 2:96-106.
20. McLennan SV, Martell SYK, Yue DK. 2000. High glucose concentration inhibits the expression of membrane type metalloproteinase by mesangial cells: Possible role in mesangium accumulation. Diabetologia 43:642-648.
21. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. 1993, Tissue inhibitor of metalloproteinase-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 157:351-358.
22. Nagase H. 1997. Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160.
23. Nagase H, Woessner JF. 1999: Matrix metalloproteinases. J Biol Chem 274:21491-21494.
24. Nguyen M, Arkell J, Jackson C. 2000. Activated protein kinase C directly activates human endothelial gelatinase A. J Biol Chem 275:9095-9098.
25. Onisto M, Riccio MP, Scannapieco P, Caenazzo C, Griggio L, Spina M. Stetler-Stevenson WG, Garbisa S. 1995. Gelatinase A/TIMP-2 imbalance in lymph-node-positive breast carcinomas, as measured by RT-PGR. Int J Cancer 63:621-626.
26. Puliese G, Pricci F, Pugliese F, Mene P, Lenti L, Andreani D, Galli G, Casini A, Bianchi S, Rotella CM. 1994. Mechansims of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes 43:478-490.
27. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. 1996. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98:2572-2579.
28. Rudermam NB, Haudenchild C. 1984. Diabetes as an atherogenic factor. Prog Cardiovasc Dis 26:373-412.
29. Schnaper HW, Grant DS, Stetler-Stetler-Stevenson WG, Fridman R, D'Orazi GD, Murphy A, Bird RE, Hoythya M, Fuerst TR, French DL. 1993. Type IV collagenases and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 156:235-246.
30. Shiozawa J, Ito M, Nakayama T, Nakashima M, Kohno S, Sekine I. 2000. Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod Pathol 13:925-933.
31. Sun LC, Luo J, Mackey LV, Fuselier JA, Coy DH. 2006. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Cancer Lett (in press).
32. The Diabetes Control and Complications Trial Research Group. 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329:977-986.
33. Uemura S, Matsushita H, Li W, Glassford AJ, Asagami T, Lee K-H, Harrison DG, Tsao PS. 2001. Diabetes mellitus enhances vascular matrix metalloproteinase activity: Role of oxidative stress. Circ Res 88:1291-1298.
34. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. 1989. SV40-transformed human lung fibroblasts secreted a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264:17213-17221.
35. Winberg J, Kolset SO, Bergh E, Uhlin-Hansen L. 2000. Macrophages secrete matrix netalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. J Mol Biol 304:669-680.